Diseases · Entity Annotation Prototype (beta)

1articles mentioning diseases

1disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: relapse/refractory solid cancers ×

relapse/refractory solid cancers

This disease is selected. Its supporting articles are shown below.

relapse/refractory solid cancers1

Articles mentioning relapse/refractory solid cancers

1 articles · page 1 of 1

518 Capivasertib, an AKT inhibitor, remodels the tumor microenvironment to synergize with combination therapy of olaparib and durvalumab in susceptible advanced/metastatic solid cancers

jitc · abstract · 2025-11-04 · 1 matching annotations

89.4%

relapse/refractory solid cancers durvalumab capivasertib Durva olaparib Ola Cap

…und The PI3K/AKT/mTOR axis is often constitutively activated in relapse/refractory solid cancers. By targeting this axis with a immune checkpoint blockade (ICB)…

Browse diseases

relapse/refractory solid cancers

Articles mentioning relapse/refractory solid cancers

518 Capivasertib, an AKT inhibitor, remodels the tumor microenvironment to synergize with combination therapy of olaparib and durvalumab in susceptible advanced/metastatic solid cancers